PIII: financial statements from SEC — TradeAlmanac

PIII

P3 Health Partners Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	386m	345m	356m	373m	362m	379m
Selling, general and administrative	26m	22m	23m	25m	27m	27m
Operating expenses	378m	389m	390m	411m	469m	410m
Operating income	8m	−44m	−34m	−38m	−107m	−31m
Pre-tax income	−8m	−69m	−42m	−43m	−106m	−28m
Income tax	−11m	11,000	2m	1m	−4m	968,000
Net income	1m	−32m	−20m	−20m	−47m	−12m
Earnings per share	0.37	−9.67	−6.23	−6.28	−14.36	−4.40
Earnings per share, diluted	0.32	−9.67	−6.23	−6.28	−15.70	−7.37
Weighted average shares	3m	3m	3m	3m	3m	3m
Weighted average shares, diluted	8m	3m	3m	3m	3m	3m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	25m	25m	38m	39m	40m	39m	63m	78m
Current assets	172m	133m	136m

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	−27m	—	—	−33m	—	—
Depreciation and amortisation	21m	21m	21m	21m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)